SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-010771
Filing Date
2022-05-04
Accepted
2022-05-04 08:15:34
Documents
15
Period of Report
2022-05-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mbrx20220503_8k.htm   iXBRL 8-K 22177
2 EXHIBIT 99.1 ex_370226.htm EX-99.1 13053
7 logo.jpg GRAPHIC 5546
  Complete submission text file 0001437749-22-010771.txt   187050

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20220504.xsd EX-101.SCH 3601
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20220504_def.xml EX-101.DEF 11532
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20220504_lab.xml EX-101.LAB 15414
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20220504_pre.xml EX-101.PRE 11688
9 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20220503_8k_htm.xml XML 2562
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 22889904
SIC: 2834 Pharmaceutical Preparations